SCM
MRK icon

Stonebridge Capital Management’s Merck MRK Stock Holding History

Stonebridge Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.5M Buy
+20,822
New +$2.4M 1.14% 27
2025
Q2 		$1.88M Hold
23,727
– – 0.73% 33
2025
Q1 		$2.13M Sell
23,727
-2,545
-10% -$238K 0.92% 30
2024
Q4 		$2.61M Sell
26,272
-500
-2% -$51.5K 1.07% 29
2024
Q3 		$3.04M Sell
26,772
-250
-0.9% -$29.7K 1.21% 27
2024
Q2 		$3.35M Sell
27,022
-100
-0.4% -$12.9K 1.43% 24
2024
Q1 		$3.58M Buy
27,122
+100
+0.4% +$12.3K 1.6% 23
2023
Q4 		$2.95M Sell
27,022
-250
-0.9% -$25.9K 1.44% 23
2023
Q3 		$2.81M Sell
27,272
-2,475
-8% -$267K 1.53% 22
2023
Q2 		$3.43M Sell
29,747
-650
-2% -$73.8K 1.6% 21
2023
Q1 		$3.23M Sell
30,397
-1,940
-6% -$209K 1.55% 23
2022
Q4 		$3.59M Sell
32,337
-665
-2% -$68K 1.71% 18
2022
Q3 		$2.84M Sell
33,002
-1,490
-4% -$133K 1.47% 23
2022
Q2 		$3.15M Sell
34,492
-3,215
-9% -$285K 1.43% 23
2022
Q1 		$3.09M Hold
37,707
– – 1.12% 28
2021
Q4 		$2.89M Sell
37,707
-1,130
-3% -$90K 1.01% 29
2021
Q3 		$2.92M Sell
38,837
-680
-2% -$51.7K 1.07% 29
2021
Q2 		$3.07M Sell
39,517
-1,168
-3% -$86.9K 1.12% 28
2021
Q1 		$2.99M Sell
40,685
-446
-1% -$32.9K 1.14% 27
2020
Q4 		$3.21M Buy
41,131
+1,226
+3% +$93.8K 1.33% 24
2020
Q3 		$3.16M Buy
39,905
+7,237
+22% +$567K 1.46% 23
2020
Q2 		$2.44M Buy
32,668
+1,446
+5% +$109K 1.25% 26
2020
Q1 		$2.29M Buy
31,222
+3,029
+11% +$238K 1.28% 26
2019
Q4 		$2.45M Sell
28,193
-262
-0.9% -$21.5K 1.07% 30
2019
Q3 		$2.29M Sell
28,455
-10,206
-26% -$818K 1.06% 30
2019
Q2 		$3.09M Sell
38,661
-10,616
-22% -$813K 1.22% 25
2019
Q1 		$3.91M Sell
49,277
-6,861
-12% -$513K 1.43% 22
2018
Q4 		$4.09M Sell
56,138
-8,641
-13% -$610K 1.64% 22
2018
Q3 		$4.38M Sell
64,779
-8,478
-12% -$540K 1.51% 24
2018
Q2 		$4.31M Sell
73,257
-263
-0.4% -$14.8K 1.54% 22
2018
Q1 		$4.01M Buy
73,520
+11,013
+18% +$595K 1.47% 23
2017
Q4 		$3.5M Buy
62,507
+12,985
+26% +$720K 1.24% 27
2017
Q3 		$3.02M Buy
49,522
+18,118
+58% +$1.1M 1.14% 28
2017
Q2 		$1.92M Buy
31,404
+20,110
+178% +$1.22M 0.73% 40
2017
Q1 		$685K Sell
11,294
-1,572
-12% -$95.4K 0.28% 66
2016
Q4 		$722K Buy
12,866
+2,358
+22% +$138K 0.3% 60
2016
Q3 		$626K Buy
10,508
+69
+0.7% +$4.04K 0.27% 62
2016
Q2 		$574K Hold
10,439
– – 0.26% 64
2016
Q1 		$527K Sell
10,439
-1,197
-10% -$58.6K 0.23% 74
2015
Q4 		$587K Sell
11,636
-290
-2% -$14.6K 0.25% 73
2015
Q3 		$562K Buy
+11,926
New +$634K 0.25% 72
2014
Q1 		– Sell
-4,726
Closed -$226K – 188
2013
Q4 		$226K Sell
4,726
-968
-17% -$44.2K 0.09% 165
2013
Q3 		$259K Hold
5,694
– – 0.12% 146
2013
Q2 		$252K Buy
+5,694
New +$254K 0.12% 146

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stonebridge Capital Management's MRK Position: Q1 2026 in Review

Stonebridge Capital Management opened a new position in Merck (MRK) in Q1 2026: 20,822 shares worth $2.5M. The stake represents 1.14% of the portfolio and ranks #27 among its holdings. This is a return to the name: Stonebridge Capital Management previously reported a position in MRK as recently as Q2 2025.

Stonebridge Capital Management first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.38M in Q3 2018. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stonebridge Capital Management held 20,822 shares of Merck worth $2.5M as of Q1 2026.
  • Merck was a new Stonebridge Capital Management position in Q1 2026.
  • Merck made up 1.14% of Stonebridge Capital Management's portfolio in Q1 2026, its #27 holding.
  • Stonebridge Capital Management first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
  • Stonebridge Capital Management's Merck position peaked at $4.38M in Q3 2018.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stonebridge Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.